Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
134.00
-2.00 (-1.47%)
Jul 29, 2026, 1:30 PM CST
Market Cap11.35B -35.9%
Revenue (ttm)4.17B -2.6%
Net Income960.76M -14.5%
EPS11.29 -14.6%
Shares Out 84.73M
PE Ratio11.87
Forward PE9.81
Dividend7.75 (5.70%)
Ex-Dividend DateMar 26, 2026
Volume338,541
Open136.50
Previous Close136.00
Day's Range130.50 - 137.50
52-Week Range122.00 - 214.50
Beta0.32
Analystsn/a
Price Targetn/a
Earnings DateAug 11, 2026

About TPEX:3218

Universal Vision Biotechnology Co., Ltd., a biotech company, provides vision care services in Taiwan and China. The company offers various glasses and lenses for vision correction, contact lens solutions, and related eye care products; equipment rental and technical services for laser vision correction instruments; and technology and services for cataract and dry eye examination and treatment instruments. It also trades in medical and pharmaceutical consumables, including ophthalmic drugs, medical supplies, and consumables; and provides adminis... [Read more]

Sector Healthcare
Founded 1992
Employees 401
Stock Exchange Taipei Exchange
Ticker Symbol 3218
Full Company Profile

Financial Performance

In 2025, TPEX:3218's revenue was 4.20 billion, a decrease of -0.57% compared to the previous year's 4.23 billion. Earnings were 1.04 billion, a decrease of -2.07%.

Financial Statements